Find a Clinical Trial
Filter
Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus
Cutaneous disorders
All genders
18+
Recruiting now
Department of Dermatology
ELATE
Tremor
All genders
18-80
Recruiting now
Department of Neurology
Ganaxolone in status epilepticus
Status epilepticus
All genders
18+
Recruiting now
Department of Neurology
BlueRock PD
Tremor
All genders
39-70
Recruiting now
Department of Neurology
OCEANIC-STROKE
Ischemic stroke, Transient ischemic attack
All genders
18+
Recruiting now
Department of Neurology
Psoriasis
Psoriasis
All genders
18+
Recruiting now
Department of Dermatology
Gemini 1
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Hercules
Multiple sclerosis
All genders
18-60
Recruiting now
Department of Neurology
PERSEUS
Multiple sclerosis
All genders
18-55
Recruiting now
Department of Neurology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center